PT Kimia Farma Tbk

KAEF

ID1000070303

Drug Retailers

End-of-day quote INDONESIA S.E. Other stock markets 18:00:00 2024-06-27 EDT			5-day change	1st Jan Change
575 ^IDR	0.00%		+0.88%	-60.21%

06-26	PT Kimia Farma Tbk Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
06-01	PT Kimia Farma Tbk Reports Earnings Results for the Full Year Ended December 31, 2023	CI

PT Asuransi Jiwa IFG agreed to acquire additional 70% stake in PT Asuransi Jiwa InHealth Indonesia from PT Kimia Farma Tbk and PT Bank Mandiri Tbk.

February 25, 2024

PT Asuransi Jiwa IFG agreed to acquire additional 70% stake in PT Asuransi Jiwa InHealth Indonesia from PT Kimia Farma Tbk (IDX:KAEF) and PT Bank Mandiri (Persero) Tbk (IDX:BMRI) on February 26, 2024.

Stocks mentioned in the article

	Add to a list Add to a list 0 selected To use this feature you must be a member Log in Sign up	Price	Change	5d. change	Capi.
	PT BANK MANDIRI (PERSERO) TBK	6,150 IDR	+2.50%	+0.41%	35.11B
	PT KIMIA FARMA TBK	575 IDR	0.00%	+0.88%	196M

Latest news about PT Kimia Farma Tbk

PT Kimia Farma Tbk Reports Earnings Results for the First Quarter Ended March 31, 2024	06-25	CI
PT Kimia Farma Tbk Reports Earnings Results for the Full Year Ended December 31, 2023	05-31	CI
PT Asuransi Jiwa IFG agreed to acquire additional 70% stake in PT Asuransi Jiwa InHealth Indonesia from PT Kimia Farma Tbk and PT Bank Mandiri Tbk.	02-25	CI
PT Kimia Farma Tbk Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-30	CI
PT Kimia Farma Tbk Reports Earnings Results for the Half Year Ended June 30, 2023	23-07-31	CI
PT Kimia Farma Tbk Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-01	CI
PT Kimia Farma Tbk Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-01	CI
Indonesia investment authority, China Silk Road Fund subscribe to Kimia Farma's convertible bonds	23-02-23	RE
PT Akar Investasi Indonesia, CIZJ Limited signed a sale and purchase deed to acquire unknown majority stake in PT Kimia Farma Apotek for IDR 460 billion.	22-12-29	CI
China's Silk Road Fund to become investor in Indonesia's state pharma firms	22-11-13	RE
PT Kimia Farma Tbk Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-31	CI
PT Kimia Farma Tbk Reports Earnings Results for the Half Year Ended June 30, 2022	22-09-29	CI
PT Kimia Farma Tbk(IDX:KAEF) dropped from S&P Global BMI Index	22-09-19	CI
PT Kimia Farma Tbk Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-30	CI
PT Kimia Farma Tbk Reports Earnings Results for the Full Year Ended December 31, 2021	22-03-30	CI
Fosun Pharma, Other Chinese Drugmakers Rise After Deal to Make Merck's Covid-19 Pill	22-01-20	DJ
PT Kimia Farma Tbk Reports Earnings Results for the Nine Months Ended September 30, 2021	21-12-07	CI
Pt Kimia Farma Persero Tbk Reports Earnings Results for the Full Year Ended December 31, 2020	21-03-30	CI
Pt Kimia Farma Persero Tbk Reports Earnings Results for the Nine Months Ended September 30, 2020	20-10-29	CI
Pt Kimia Farma Persero Tbk Reports Earnings Results for the Half Year Ended June 30, 2020	20-07-30	CI
PT Kimia Farma Persero Tbk : Indonesia gives tax break to makers of personal protective equipment	20-06-19	RE
Pt Kimia Farma Persero Tbk Reports Earnings Results for the Full Year Ended December 31, 2019	20-03-26	CI
Pt Kimia Farma Persero Tbk Reports Earnings Results for the Nine Months Ended September 30, 2019	19-11-01	CI
PT Kimia Farma Tbk(IDX:KAEF) added to S&P Global BMI Index	19-09-23	CI
Pt Kimia Farma Persero Tbk Reports Earnings Results for the Half Year Ended June 30, 2019	19-09-02	CI

Chart PT Kimia Farma Tbk

Duration

Period

More charts

Company Profile

PT Kimia Farma Tbk is an Indonesia-based company, which is engaged in producing, distributing, and marketing chemical industry product, active pharmaceutical ingredients (API) and high function chemicals (HFC). Its segments include Manufacturing, Distribution, Retail, and Other. The Manufacturing segment includes chemical and pharmaceutical manufacturing, research and development, and manufacturing marketing and marketing of quinine and essential oils; manufacturing and marketing of active pharmaceutical ingredients and HFC, and manufacturing and marketing of pharmaceutical products. The distribution segment is engaged in distribution of pharmaceutical products to domestic market and to the international market, including Saudi Arabia, the United States, Netherlands, the United Kingdom, China, Malaysia, and several other countries. The Retail segment is engaged in the sale of medicines and pharmaceutical products directly to customers.

Sector

Drug Retailers

Calendar

2024-07-30 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Drug Retailers

	1st Jan change	Capi.
PT KIMIA FARMA TBK	-60.21%	196M
WALGREENS BOOTS ALLIANCE, INC.	-53.68%	10.44B
JD HEALTH INTERNATIONAL INC.	-45.65%	8.68B
ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED	-26.18%	6.45B
MATSUKIYOCOCOKARA & CO.	-7.49%	5.98B
CORPORATIVO FRAGUA, S.A.B. DE C.V.	+85.61%	4.91B
NAHDI MEDICAL COMPANY	-3.80%	4.57B
CLICKS GROUP LIMITED	+5.73%	4.49B
YIFENG PHARMACY CHAIN CO., LTD.	-26.42%	4.1B
WELCIA HOLDINGS CO., LTD.	-18.65%	2.58B

Other Drug Retailers

PT Kimia Farma Tbk

Equities

KAEF

ID1000070303

Drug Retailers

PT Asuransi Jiwa IFG agreed to acquire additional 70% stake in PT Asuransi Jiwa InHealth Indonesia from PT Kimia Farma Tbk and PT Bank Mandiri Tbk.

Stocks mentioned in the article

Latest news about PT Kimia Farma Tbk

Chart PT Kimia Farma Tbk

Company Profile

Income Statement Evolution

Sector Other Drug Retailers